1-6 of 6
Natalia Becker
Close
Sort by
Journal Articles

Salvage Autologous Transplant and Lenalidomide Maintenance Versus Continuous Lenalidomide/Dexamethasone for Relapsed Multiple Myeloma: Results of the Randomized GMMG Phase III Multicenter Trial Relapse

Hartmut Goldschmidt, MD, Marc-A. Baertsch, MD, Jana Schlenzka, MD, Natalia Becker, PhD, Habermehl Christina, PhD, Thomas Hielscher, Marc S Raab, MD, Jens Hillengass, MD, Carsten Müller-Tidow, MD, Steffen Luntz, MD, Anna Jauch, PhD, Peter Brossart, MD, Martin Goerner, MD, Stefan A Klein, MD, Martin Schmidt-Hieber, MD PhD, Peter Reimer, MD, Ullrich Graeven, MD, Roland Fenk, MD PhD, Mathias Haenel, MD, Hans Martin, MD, Hans-Walter Lindemann, MD, Christoph Scheid, MD, Axel Nogai, MD, Hans Jürgen Salwender, MD, Richard Noppeney, MD, Katja Weisel, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 253.
https://doi.org/10.1182/blood-2018-99-111203
Published: 2018
Journal Articles

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis

Tobias Dittrich, Tilmann Bochtler, Christoph Kimmich, Natalia Becker, Anna Jauch, Hartmut Goldschmidt, Anthony D. Ho, Ute Hegenbart, Stefan O. Schönland
Journal: Blood
Blood (2017) 130 (5): 632–642.
https://doi.org/10.1182/blood-2017-02-767475
Published: 2017
Includes: Supplemental data
Journal Articles

Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial

Patrick Wuchter, MD, Uta Bertsch, MD, Hans-Juergen Salwender, MD, Markus Munder, MD, Mathias Haenel, MD, Axel Benner, Natalia Becker, PhD, Roland Fenk, MD, Jan Duerig, MD, Igor Wolfgang Blau, MD, Katharina Lisenko, MD, Jens Hillengass, MD, Marc S. Raab, MD, Marc Andrea Baertsch, MD, Andrea Seidel-Glaetzer, Anthony D Ho, MD, Ullrich Graeven, MD, Christof Scheid, MD, Katja Weisel, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2016) 128 (22): 3373.
https://doi.org/10.1182/blood.V128.22.3373.3373
Published: 2016
Journal Articles

Analysis of Long-Term Survival in Multiple Myeloma Patients after First-Line Autologous Stem Cell Transplantation: Impact of Clinical Risk Factors and Duration of Response

Nicola Lehners, MD, Natalia Becker, PhD, Axel Benner, Maria Pritsch, Elias Karl Mai, MD, Jens Hillengass, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD
Journal: Blood
Blood (2016) 128 (22): 4649.
https://doi.org/10.1182/blood.V128.22.4649.4649
Published: 2016
Journal Articles

Pre-Transplant Weight Loss Influences Outcome of Patients with Myelodysplastic Syndrome Undergoing Allogeneic Stem Cell Transplantation

Aleksandar Radujkovic, MD, Natalia Becker, Axel Benner, Sascha Dietrich, MD, Olaf Penack, Uwe Platzbecker, MD, Friedrich Stölzel, MD, Martin Bornhäuser, MD, Ute Hegenbart, MD, Anthony D Ho, MD, Peter Dreger, MD, Thomas Luft
Journal: Blood
Blood (2014) 124 (21): 3950.
https://doi.org/10.1182/blood.V124.21.3950.3950
Published: 2014
Journal Articles

High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response

Marc Remke, Stefan Pfister, Corinne Kox, Grischa Toedt, Natalia Becker, Axel Benner, Wiebke Werft, Stephen Breit, Shuangyou Liu, Felix Engel, Andrea Wittmann, Martin Zimmermann, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Claus R. Bartram, Bernhard Radlwimmer, Martina U. Muckenthaler, Peter Lichter, Andreas E. Kulozik
Journal: Blood
Blood (2009) 114 (5): 1053–1062.
https://doi.org/10.1182/blood-2008-10-186536
Published: 2009
Includes: Supplemental data